News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, July 23, 2018

We are pleased to share the summer issue of Research News highlighting the outstanding research

activities across the University of Oklahoma Health Sciences Center (OUHSC). The purpose of this

quarterly newsletter is to inform you of the exciting research and scholarly work being conducted by

our OUHSC faculty, students, and staff. 

If you are interested in having your work or that of your peers, staff, and/or students published in the

newsletter or publishing a research related press release, please contact Samantha Skrepnek at

Samantha-Skrepnek@ouhsc.edu.

http://research.ouhsc.edu/Portals/1329/Assets/Documents/Research News_Summer 2018 Issue.pdf?ver=2018-07-23-073422-977

 

The Office for Human Research Protections (OHRP) is announcing the availability of

three draft guidance documents that relate to three burden-reducing provisions in the revised

Common Rule that institutions may choose to implement during the delay period (July 19, 2018

through January 20, 2019) for general compliance with the revised Common Rule.  The three draft

guidance documents are titled:
1.      Scholarly and Journalistic Activities Deemed Not to be Research: 2018 Requirements; it can

be accessed at

https://www.hhs.gov/ohrp/regulations-and-policy/requests-for-comments/draft-guidance-scholarly-and-journalistic-activities-deemed-not-to-be-research/index.html.
2.      When Continuing Review Is Not Required During the 6-Month Delay Period of July 19, 2018

through January 20, 2019: 2018 Requirements; it can be accessed at

https://www.hhs.gov/ohrp/regulations-and-policy/requests-for-comments/draft-guidance-when-continuing-review-is-not-required-during-the-6-month-delay-period/index.html.
3.      Elimination of Institutional Review Board (IRB) Review of Research Applications and Proposals:

2018 Requirements; it can be accessed at

https://www.hhs.gov/ohrp/regulations-and-policy/requests-for-comments/draft-guidance-elimination-of-irb-review-of-research-applications-and-proposals/index.html.
OHRP plans to issue a Federal Register Notice of Availability (NOA) about these draft guidance

documents soon, but is posting the draft guidance documents here in recognition of the general

compliance delay period, which began July 19, 2018. The NOA that will be issued will include a

docket for each draft document in which the public can submit comments during a 30-day period

(starting from the day the NOA publishes).
Note: this listserv announcement will be updated and sent out to subscribers once the NOA is issued.
Additional information on the revised Common Rule and the three burden-reducing provisions can

be accessed at:

https://www.hhs.gov/ohrp/regulations-and-policy/regulations/finalized-revisions-common-rule/index.html.

 

 

Registration Now Open for NIH Workshop on Single IRB Resource and Infrastructure

Development

On September 12, 2018, NIH will be holding a public workshop on successful strategies and lessons

learned for modifying and enhancing institutional IRB infrastructure for single IRB review of multi-site

studies. The meeting will take place at the Hilton Washington DC/Rockville Hotel & Executive Meeting

Center in Rockville, MD.

The “Final NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research,”

establishes the expectation that the domestic sites of all NIH-funded multi-site studies involving

non-exempt human subjects research will use a single Institutional Review Board. NIH has heard a

great deal of positive feedback in support of the policy and believes that streamlining IRB review for

multi-site studies will reduce unnecessary delays and costs caused by duplicative review. 

Additionally, NIH previously funded seven administrative supplements that provided one year of

support to develop widely applicable approaches for modifying and enhancing institutional IRB

infrastructure and related resources to allow for efficient and effective single IRB review of multi-site

studies.  This workshop will bring together those awardees to share the innovative strategies they

have developed.

More information about this workshop, including how to register can be found at:

https://osp.od.nih.gov/single-irb-review-workshop-registration/

While there is no fee to register, seating is limited.  The workshop will also be webcast.

If you have any questions, please contact us at SciencePolicy@od.nih.gov  

 

 

Applications for PHF Bridge Grant

Proposal Deadline Friday, August 17, 2018

The primary objective of the PHF Bridge Grant program is to provide funding of limited duration to

enhance OUHSC faculty competitiveness for NIH R01 and Department of Defense (DoD) extramural

funding.  PHF Bridge Grant funding is specifically for those OUHSC faculty members who have

submitted R01 applications to NIH or applications to DoD that have been reviewed and scored,

but not funded.   Applicants may request support of up to $75,000 for one year.

Guidelines and Application Form are attached or go to:

http://research.ouhsc.edu/ResearchAdministration/Grants/FundingSources/PHFGrantInformation.aspx

http://research.ouhsc.edu/Portals/1329/Assets/Documents/PHF-Bridge Grant-Guidelines - Final - August-September 2018.docx?ver=2018-07-23-073457-197

 

NIH NOTICES

 

NHLBI Announces Participation in PA-17-444 "Ethical, Legal, and Social Implications (ELSI) of

Genomics Research Project Grant Program (R01)" (NOT-HL-18-621)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-621.html

 

NIAID OMNIBUS BROAD AGENCY ANNOUNCEMENT No. HHS-NIH-NIAID-BAA2018: Soliciting

Proposals for Antimicrobial Products, Novel Vaccines and Technologies Against Category A, B, and

C Agents, and Universal Influenza Vaccines (NOT-AI-18-048)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-18-048.html

 

Notice Announcing FAQs Page for PAR-18-307 "Developing Interventions for Health-Enhancing

Physical Activity (R21/R33 - Clinical Trial Optional)" and PAR-18-324 "Testing Interventions for Health-

Enhancing Physical Activity (R01 - Clinical Trial Optional)" (NOT-OD-18-208)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-208.html

 

Notice of Change to Instructions for NOT-OD-18-195 "Notice of Availability of Administrative

Supplements for NIH Grants Focused on Down Syndrome to Address Specific Down Syndrome

Research Objectives" (NOT-OD-18-203)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-203.html

 

Notice of Change to Instructions for NOT-OD-18-194 "Notice of Availability of Administrative

Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down

Syndrome Research Objectives (NOT-OD-18-204)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-204.html

 

Notice of Change to the Research Areas of Focus for PAR-17-267 "Modeling of Infectious Disease

Agent Study Research Projects (R01)" (NOT-AI-18-039)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-18-039.html

 

Notice of Change of Requirements for RFA-DA-19-002, "Development of Medications to Prevent

and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) (NOT-DA-18-016)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-016.html

 

Notice of Change to Due Date and Foreign Institutions Eligibility for Applications to RFA-HD-19-018:

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research

(R21 - Clinical Trial Not Allowed) (NOT-HD-18-014)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-014.html

 

Notice of Clarification of Eligible Individuals [Program Director(s)/Principal Investigator(s)] for

RFA-DK-18-009, Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial

Not Allowed) (NOT-DK-18-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-18-018.html

 

Notice of NCI Participation in PA-18-343, "Academic Research Enhancement Award (R15 Clinical

Trial Required)" (NOT-CA-18-094)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-094.html

 

Notice of NHGRI Interest in Receiving Letters Requesting Permission to Submit Applications to

Support Biennial ELSI Research Conferences (U13) (NOT-HG-18-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-18-009.html

 

Notice of NHLBI Participation in PA-18-723 "Improving Patient Adherence to Treatment and

Prevention Regimens to Promote Health (R21 Clinical Trial Optional)" (NOT-HL-18-640)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-640.html

 

Notice of NHLBI Participation in PA-18-722 "Improving Patient Adherence to Treatment and

Prevention Regimens to Promote Health (R01 Clinical Trial Optional)" (NOT-HL-18-641)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-641.html

 

Notice of NICHD Participation in PAR-17-471 "Detection of HIV for Self-Testing (R61/R33)"

(NOT-HD-18-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-008.html

 

Notice of Information for HIV research priorities at the National Heart, Lung, and Blood Institute

(NOT-HL-18-642)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-642.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for The National Drug Abuse

Treatment Clinical Trials Network (UG1) Clinical Trial Optional (NOT-DA-18-024)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-024.html

 

Notice of NIDCD and NEI Interest in Supporting Research on Usher Syndrome (NOT-DC-18-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-DC-18-007.html

 

Notice of Intent to Publish Funding Opportunity Announcement to Promote Screening and

Management of Unhealthy Alcohol Use in Primary Care (R18) (NOT-HS-18-011)
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-18-011.html

 

Request for Information (RFI): Challenges and Opportunities in Understanding Nuclear Organization

in Space and Time (4D Nucleome) (NOT-RM-18-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-RM-18-017.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial

Not Allowed) (PA-18-853) – Deadline November 27, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-853.html

 

Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)

(RFA-DE-19-004) – Deadline October 4, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-19-004.html

 

Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial

Required) (RFA-AI-18-036) – Deadline January 3, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-18-036.html

 

Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource

Registry (U24 Clinical Trial Not Allowed) (RFA-DC-19-002) – Deadline October 23, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-19-002.html

 

NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars

(Admin Supp Clinical Trials Optional) (PA-18-851) – Deadline December 11, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-851.html

 

Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional) (PA-18-849)

Deadline October 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-849.html

 

Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional) (PA-18-850)

Deadline October 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-850.html

 

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) (PAR-18-854)

Deadline August 23, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-854.html

 

 

New Clinical Study Opportunities

**************************************************************

Please note this is NOT a solicitation for study subjects

**************************************************************

Several Pharmaceutical companies are looking for Principal Investigators to participate in the following

clinical studies:

  • Osteoporosis postmenopausal  00114071
  • Acute coronary syndrome  00114806
  • Acute Myeloid Leukemia  00114106
  • Melanoma  00113464
  • Chronic renal failure  00111552
  • Non-Hodgkin lymphoma  00115736
  • Non-small cell lung cancer  00116101
  • Crohn's disease  00110979
  • Dermatitis  00105496
  • Diabetes  00103896
  • Rheumatoid arthritis  00114994
  • A PHASE 1-2 DOSE-ESCALATION AND COHORT-EXPANSION STUDY OF ORAL EFT508

IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES non-GCB DLBCL

Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on

any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed

to the Office of Research Administration.

Print

Name:
Email:
Subject:
Message:
x